Daily Management Review

Vertex Pharma Receives A Subpoena


10/31/2015


A subpoena brought the Vertex Pharma’s shares into attention.



According to StreetInsider the shares of “Vertex Pharma” came into the limelight on Friday the 30th October 2015.
 
This incident took place once the company had “filed its 10-Q”. The said filing has demonstrated a “subpoena” in the Q3 section.
 
The StreetInsider quotes one portion of the filing which recounts the incident of subpoena. The extract goes like this:
“In the third quarter of 2015, we received a subpoena from the United States Department of Justice related to our marketed medicines. This subpoena requests documents relating primarily to our Good Laboratory Practices in a bioanalytical laboratory. We are in the process of responding to the subpoena and intend to cooperate”.




References:
www.streetinsider.com
 







Science & Technology

Airbus: Passenger hybrid aircraft to take off before 2035

Ocado To Introduce ‘Mini Robotic Warehouse’ With Standard Productivity

AB InBev’s Piled Up Alcohol Is ‘Too Good to Waste’

Ericsson Mobility forecasts nearly fourfold increase in mobile traffic by 2025

Elon Musk: We received 146,000 orders for Cybertruck

Google turns the screws on political ads

Apple to come up with AR glasses

WEF: Big data regulation becomes a problem

Israeli Firm Accused Of Spying By WhatsApp, Lawsuit Filed Against It

Google Used Quantum Computer To Solve Complex Problem

World Politics

World & Politics

Poland refuses to join EU 2050 climate deal

EU to fight food waste

Mexico approves amendments to NAFTA

Finnish parliament to vote for prime minister

Protests in France gain the greatest scale since 2010

Massive blackout unfolds in Venezuela

French And Russian Presidents To Discuss The Moratorium On Missiles In Europe

EU adopts budget for 2020, more funds allocated to climate change fight and innovation